Melanie Daniel: A Landmark Session on Hemophilia and Rare Bleeding Disorders at the National Academy of Medicine
Melanie Daniel, Physician at Lille University Hospital, shared on LinkedIn:
”A landmark session on hemophilia and rare bleeding disorders at the National Academy of Medicine
Last week, the National Academy of Medicine hosted an outstanding public session dedicated to hemophilia and other rare bleeding disorders, bringing together clinical, translational, and therapeutic perspectives on a rapidly evolving field.
The session showcased major advances in patient management, innovative biology, gene therapy, and progress in rare disorders of hemostasis.
Scientific contributions included:
• Hemophilia and the evolution of patient management
Sophie Susen
• Nanobodies and therapeutic antibodies: a revolution
Peter Lenting
• Gene therapy in hemophilia
Antoine Rauch
• Advances in other rare hemostatic disorders
Cécile Denis
A great recognition of the work carried out by UMR1011 – Team 2, with the active participation of Prof. sophie susen and Prof. Antoine Rauch, and of the strength of long-standing scientific collaborations with Cécile DENIS and Peter Lenting at UMR1176 HITh lab Inserm.
Missed the session?
The full recording is available on the Academy’s YouTube channel.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice